- Home
- GTBP vs RSLS Comparison
GTBP vs RSLS Comparison
Compare GTBP & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- RSLS
- Stock Information
- Founded
- GTBP 1965
- RSLS 2002
- Country
- GTBP United States
- RSLS United States
- Employees
- GTBP N/A
- RSLS N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- RSLS Medical/Dental Instruments
- Sector
- GTBP Health Care
- RSLS Health Care
- Exchange
- GTBP Nasdaq
- RSLS Nasdaq
- Market Cap
- GTBP 5.5M
- RSLS 4.5M
- IPO Year
- GTBP N/A
- RSLS 2007
- Fundamental
- Price
- GTBP $2.28
- RSLS $0.38
- Analyst Decision
- GTBP Strong Buy
- RSLS Hold
- Analyst Count
- GTBP 1
- RSLS 1
- Target Price
- GTBP $11.00
- RSLS N/A
- AVG Volume (30 Days)
- GTBP 14.8K
- RSLS 44.2M
- Earning Date
- GTBP 05-14-2025
- RSLS 04-04-2025
- Dividend Yield
- GTBP N/A
- RSLS N/A
- EPS Growth
- GTBP N/A
- RSLS N/A
- EPS
- GTBP N/A
- RSLS N/A
- Revenue
- GTBP N/A
- RSLS $8,006,000.00
- Revenue This Year
- GTBP N/A
- RSLS $52.80
- Revenue Next Year
- GTBP N/A
- RSLS N/A
- P/E Ratio
- GTBP N/A
- RSLS N/A
- Revenue Growth
- GTBP N/A
- RSLS N/A
- 52 Week Low
- GTBP $1.72
- RSLS $0.30
- 52 Week High
- GTBP $10.66
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- GTBP 48.56
- RSLS 42.48
- Support Level
- GTBP $2.15
- RSLS $0.37
- Resistance Level
- GTBP $2.38
- RSLS $0.49
- Average True Range (ATR)
- GTBP 0.17
- RSLS 0.11
- MACD
- GTBP -0.01
- RSLS 0.04
- Stochastic Oscillator
- GTBP 32.35
- RSLS 19.28
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.